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A. Optimization of SVM parameters 
The RBF kernel parameter gamma and the SVM cost parameter C were optimized by 
performing a coarse two dimensional grid search over combinations of C ={2,4,6,8,10} 
and γ = {2,4,6,8,10}, with a finer grid search over combinations of C = {2,3,4,5,6} and γ 
= {3,4,5}. A 10 fold cross validation was used to evaluate the average ROC AUC score 
for each combination of γ and C. The parameters values yielding the predictor with the 
highest ROC AUC score were used. LibSVM was used to build the SVMs [1]. 
B. Constructing phage display data enriched in 
genomic-like or non genomic-like interactions 
Categorization of human phage display domains 
From the Tonikian et al. data set, 31 out of 54 human phage display domains were used 
to create data sets enriched in genomic-like or non genomic-like interactions [2].  A 
peptide was genomic-like if its last four residues matched a protein tail from the human 
proteome (Ensembl:GRCh37.56), otherwise it was non genomic-like. Depending on how 
many unique interacting genomic-like or non genomic-like peptides, domains were then 
categorized as genomic-like, non genomic-like, dual or non specific according to the 
definitions in Table S1. The categorized domains are listed in Table S2. 
 
Table S1. The following table summarizes the domain category definitions used to 
identify genomic-like, non genomic-like, dual and non specific domains in the phage 
display data set. The number of unique genomic-like peptides is the number of unique 
peptides that match a human protein tail (based on the last four residues in the peptide).  
Category  # Unique 
genomic-like 
# Unique non 
genomic-like   - 3 - 
interactions  interactions 
Genomic-like  ≥ 10  < 10 
Non genomic-like  < 10  ≥ 10 
Dual  ≥ 10  ≥ 10 
Non specific  < 10  < 10 
 
Table S2. The following table lists the categorization of human phage display domains 
based on the definitions in Table S1. The number of unique genomic-like peptides is the 
number of unique interacting peptides that match a human protein tail (based on the last 
four residues in the peptide).  
Tonikian 
Domain Name 
# Unique 
genomic-like 
peptides 
# Unique non 
genomic-like 
peptides 
Category 
 
DLG3-2  11  7  Genomic-like 
PTPN13-2  11  9  Genomic-like 
DLG1-2  18  22  Dual 
MPDZ-1  11  48  Dual 
MPDZ-3  11  24  Dual 
SHANK3-1  21  13  Dual 
APBA3-1  4  13  Non Genomic-like 
DVL2-1  4  10  Non Genomic-like 
HTRA2-1  2  28  Non Genomic-like 
MAGI3-3  3  12  Non Genomic-like 
MPDZ-13  6  12  Non Genomic-like 
MPDZ-2  2  24  Non Genomic-like 
MPDZ-7  3  15  Non Genomic-like 
PDLIM2-1  1  23  Non Genomic-like 
PSCDBP-1  4  46  Non Genomic-like 
PTPN13-4  2  12  Non Genomic-like 
TJP1-1  5  19  Non Genomic-like 
DLG1-1  4  5  Non Specific 
DLG1-3  8  3  Non Specific 
DLG2-3  6  3  Non Specific 
DLG4-3  7  5  Non Specific 
ERBB2IP-1  3  9  Non Specific 
INADL-2  2  4  Non Specific 
LRRC7-1  3  5  Non Specific 
MAGI1-4  3  9  Non Specific 
MPDZ-10  6  7  Non Specific 
MPDZ-12  1  7  Non Specific   - 4 - 
PDLIM4-1  2  8  Non Specific 
SCRIB-1  8  2  Non Specific 
SCRIB-2  2  3  Non Specific 
SNTA1-1  6  4  Non Specific 
 
Constructing human phage display enriched in genomic-like or non genomic-like 
interactions 
For a data set enriched in genomic-like interactions, only non genomic-like and dual 
domains were pre-processed and used for training. From these domains, all non genomic-
like interactions were removed. If doing so resulted in a domain with less than 10 unique 
genomic-like peptides, this domain was not used for training. Data from genomic-like 
and non specific domains (if they had ≥ 10 interactions in total) were used without any 
pre-processing.  In total, 20 human domains were used for training. For a data set 
enriched in non genomic-like interactions, only genomic-like and dual domains were pre-
processed. From these domains, all genomic-like interactions were removed. If doing so 
resulted in a domain with less than 10 unique interacting non genomic-like peptides, that 
domain was not used for training. Data from non genomic-like and non specific domains 
were used without any pre-processing. In total, 29 human domains were used for training 
in this case. Table S3 contains a summary of the genomic-like and non genomic-like 
phage display training data sets. 
 
Table S3. The following table summarizes the human phage display data used for 
training. * denotes interactions used to create phage display training data enriched in 
genomic-like interactions. ** denotes interactions used to create phage display training 
data enriched in non genomic-like interactions.  
Tonikian 
Domain Name 
Total # 
genomic-like 
Total # non 
genomic-like 
Total # 
interactions   - 5 - 
interactions  interactions 
DLG3-2  16  12  28 * 
PTPN13-2  14  10  24 * 
DLG1-2  22 *  26 **  48 
MPDZ-1  14 *  51 **  65 
MPDZ-3  12 *  25 **  37 
SHANK3-1  35 *  17 **  52 
APBA3-1  4  14  18 ** 
DVL2-1  4  18  22 ** 
HTRA2-1  0  30  32 ** 
MAGI3-3  2  12  15 ** 
MPDZ-13  9  29  42 ** 
MPDZ-2  3  32  35 ** 
MPDZ-7  13  25  28 ** 
PDLIM2-1  3  40  41 ** 
PSCDBP-1  3  69  75 ** 
PTPN13-4  1  20  22 ** 
TJP1-1  6  24  39 ** 
DLG1-1  6  12  12 *,** 
DLG1-3  10  13  13 *,** 
DLG2-3  10  14  14 *,** 
DLG4-3  9  16  16 *,** 
ERBB2IP-1  7  33  33 *,** 
INADL-2  3  11  11 *,** 
LRRC7-1  3  26  26 *,** 
MAGI1-4  3  12  12 *,** 
MPDZ-10  8  16  16 *,** 
MPDZ-12  2  11  11 *,** 
PDLIM4-1  2  10  10 *,** 
SCRIB-1  23  27  27 *,** 
SCRIB-2  2  16  16 *,** 
2SNTA1-1  7  11  11 *,** 
 
Human phage display domains excluded from training 
In total 23 domains were not used for testing. Five domains had less than 10 peptides in 
total and the binding site sequence alignments for 17 domains did not align well to other 
PDZ domains (i.e. had at least one gap). The domain MLLT4-1 was also not used since 
we could not predict any negatives for it. Table S4 contains a summary of the phage 
display domains, which were not used for training.   - 6 - 
 
Table S4. The following table lists the PDZ domains that were not used for training and 
the reasons for exclusion. 
Tonikian 
Domain Name 
# Interactions  Reason for 
exclusion 
INADL-3  8  < 10 
INADL-6  7  < 10 
LIN7A-1  6  < 10 
PARD3-3  5  < 10 
PTPN4-1  6  < 10 
CASK-1  20  Gapped 
HTRA1-1  14  Gapped 
HTRA3-1  66  Gapped 
MAGI1-2  48  Gapped 
MAGI3-2  15  Gapped 
MPDZ-4  4  Gapped 
MPDZ-5  13  Gapped 
MPDZ-9  26  Gapped 
MPP6-1  17  Gapped 
PDZK1-1  30  Gapped 
PDZK1-2  8  Gapped 
SCRIB-3  32  Gapped 
SLC9A3R2-2  37  Gapped 
TIAM1-1  8  Gapped 
TIAM2-1  7  Gapped 
TJP1-3  33  Gapped 
TJP2-3  32  Gapped 
MLLT4-1  116  No negatives 
predicted 
 
C. Artificial negatives for phage display training data 
Using the 20 human phage display profiles from the previous section, different negative 
interactions were generated using the following methods. The same number of negatives 
was generated for each method. 
   - 7 - 
a.  Random: Given a domain, negative peptides were created by generating sequences of 
random residues of length five. 
b.  Shuffled: Given a domain, negative peptides were created by shuffling the residues of 
positive binders. 
c.  Random Selection: All unique peptides from the positive training interactions were 
put into a list to create a pool of peptides. Given a domain, peptides were randomly 
selected from this list. 
d.  PWM: All unique peptides from the positive training interactions were put into a list 
to create a pool of peptides. Given a domain with a corresponding set of positive 
peptide sequences (representing positive interactions determined from phage display), 
the following steps were taken to determine low scoring and low redundancy artificial 
negatives: 
1.  A PWM was built using the positive peptide sequences and the minimum PWM 
score amongst the positive peptides was set to be the cutoff. 
2.  All unique peptides in the pool were scored with the PWM from step 1 and sorted 
in descending order according to PWM score. Walking down the sorted list, 
peptides were selected based on two criteria: 
i.  Low scoring: the PWM score must be lower than the cutoff  
ii.  Low redundancy: The similarity of the peptide to peptides already selected 
must be below the redundancy threshold (in our case it must have less than 
three residues in common with negative peptides already selected). The choice 
of our redundancy threshold is explained in detail below.   - 8 - 
D. Choosing the number of peptides in common to 
remove for peptide redundancy reduction 
When selecting negative peptides in step 2 of the previous section, only peptides with 
less than three residues in common with those already selected were used. We optimized 
this redundancy threshold by building different SVMs trained using artificial negatives 
selected using different redundancy thresholds (1,2,3,4,5). For example, using a low 
threshold (less than one residue in common) would allow fewer but a more diverse set of 
negatives to be selected than using a higher threshold (less than five in common) which 
would allow a greater number but an overall less diverse set of negatives to be selected. 
The SVM with the highest ROC and PR AUCs was used and corresponded to a 
redundancy threshold of three (Figure. S1).  
 
Figure S1. (Top row) ROC AUC comparison for predictors trained using data with 
different levels of peptide redundancy. (Bottom row) PR AUC comparison for predictors 
trained using data with different levels of peptide redundancy. Black coloured bars 
indicate the number used for our final SVM.   - 9 - 
 
 
E. Implementation details for published and commonly 
used predictors 
Several predictors for the prediction of PDZ domain interactions were used in this paper 
are discussed in more detail here. Binding site refers to the 16 domain sequence positions 
found to be in contact with the peptide ligand as described by Chen et al. [3]. 
Position Weight Matrix 
Position weight matrices (PWMs) for each training domain were built using their known 
binders and represented their binding preferences. Thus the cells of the position weight 
matrices contain the log probability of each residue at each of the positions in the binding 
peptide.  Since some amino acids occur more frequently than others, this bias is corrected 
for by dividing the PWM residue frequencies by their expected frequencies using the 
NNK codon set (where N represents a 25% mix each of adenine, thymine, guanine, and 
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cytosine nucleotides; and K represents a 50% mix each of thymine and guanine 
nucleotides) [4].  To avoid negative infinity values in the PWM, any residues with a 
frequency of zero are assigned the pseudocount of 0.01. The binding preference of a 
domain for a given peptide sequence is then computed by summing the weights in the 
matrix corresponding to each residue and position in the given sequence. If the score is 
above a specified cut off, the peptide is predicted to bind otherwise it is predicted to not 
bind. Using the nearest neighbour PWM of a given test domain (as determined by 
binding site sequence similarity), a list of peptides is evaluated and ordered in descending 
order by PWM score. The top 1% of this ordered list is then predicted to be binders. In 
total, interactions for 82 mouse from protein microarray and 20 human domains from 
phage display experiments as described in the paper were used to build the PWMs. 
Nearest Neighbour  
A nearest neighbour (NN) predictor was built and determined whether or not a given 
interaction was positive or negative using a nearest neighbour criterion. The nearest 
neighbour criterion is evaluated by computing the Hamming distance between a test 
interaction and all other training interactions (where interactions are represented as a 
domain binding site–peptide sequence pair). The training interaction with the lowest 
distance is then set to be the test interaction’s nearest neighbour. Thus if the nearest 
neighbour is a positive interaction, the test interaction is predicted to be positive, 
otherwise it is predicted to be negative. In total, interactions for 82 mouse domains from 
protein microarray and 20 human domains from phage display as described in the paper 
were used to build the NN predictor.   - 11 - 
Multidomain Selectivity Model 
This multidomain selectivity model (MDSM) was built by Stiffler et al. [5] and computes 
the individual binding preferences of a given peptide to each mouse PDZ domain 
represented in the model. For our purposes, the binding preference of a given peptide was 
computed using the model parameters corresponding to its nearest model domain as 
determined by the Hamming distance between the binding site sequences. A given 
peptide is predicted to be positive if the binding preference score is greater than a 
predetermined threshold (we used the parameter m = 5 according to the original 
publication). In total 74 mouse PDZ domains were modelled. 
Additive Model 
We used the model parameters as specified in the tutorial provided in the supplemental 
material of the original publication [3]. The value of tau used was -0.3978. In total, 82 
mouse domains from the Stiffler et al. protein microarray experiment were used for 
training in the original publication.  
F. Detailed summary of proteome scanning results 
The following is a summary of the results of proteome scanning in different organisms 
using the SVM, MDSM, additive model and PWM predictor. Method is the name of the 
predictor used, Domain is the name of the domain that the proteome is being scanned for, 
NN Sim is the similarity of the scanning domain to its nearest training neighbour, Num 
predicted is the number of positive predictions made by the predictor, #TP is the number 
of positive predictions validated to be positive, #FP is the number of positive predictions 
that were validated to be negative, #Valid Positives is the number of positive validation 
interactions, #Valid Negatives is the number of negative validation interactions. Only   - 12 - 
validation interactions involving genomic peptides (as defined by the Ensembl genome 
assemblies) were used. 
Human 
The human proteome was scanned to predict interactions for 13 human PDZ domains 
with available interactions from PDZBase [6]. In total, 41,193 unique transcript tails of 
length five out of 77,748 transcripts corresponding to 23,675 genes from the human 
proteome were scanned (defined by Ensembl:GRCh37.56 genome assembly) [7].  
 
Table S5. The following table summarizes the human proteome scanning results for the 
SVM, MDSM, Additive and PWM predictors 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
SVM  DLG1-1  1.0  283  2  0  2  0 
SVM  DLG1-2  1.0  389  3  0  3  0 
SVM  MPDZ-10  1.0  199  3  0  4  0 
SVM  ERBB2IP-1  1.0  83  2  0  2  0 
SVM  DLG3-2  1.0  389  1  0  2  0 
SVM  LIN7B-1  1.0  422  1  0  2  0 
SVM  DLG4-1  0.9375  223  2  0  2  0 
SVM  DLG4-2  0.9375  294  2  0  2  0 
SVM  PDZK1-1  0.8125  551  1  0  1  0 
SVM  MLLT4-1  0.6875  36  1  0  6  0 
SVM  MAGI3-1  1.0  1185  0  0  1  0 
SVM  MAGI2-2  1.0  694  0  0  1  0 
SVM  SNTG1-1  1.0  680  1  0  1  0 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
MDSM  DLG1-1  1.0  269  2  0  2  0 
MDSM  DLG1-2  0.875  269  3  0  3  0 
MDSM  MPDZ-10  1.0  2534  1  0  4  0 
MDSM  ERBB2IP-1  1.0  825  0  0  2  0 
MDSM  DLG3-2  0.875  269  1  0  2  0 
MDSM  LIN7B-1  1.0  165  2  0  2  0 
MDSM  DLG4-1  0.9375  269  2  0  2  0 
MDSM  DLG4-2  0.8125  269  2  0  2  0 
MDSM  PDZK1-1  0.9375  11  0  0  1  0   - 13 - 
MDSM  MLLT4-1  0.6875  285  1  0  6  0 
MDSM  MAGI3-1  0.6875  1070  0  0  1  0 
MDSM  MAGI2-2  0.75  1070  0  0  1  0 
MDSM  SNTG1-1  0.875  613  1  0  1  0 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
Additive  DLG1-1  1.0  2094  2  0  2  0 
Additive  DLG1-2  1.0  2241  3  0  3  0 
Additive  MPDZ-10  1.0  52  0  0  4  0 
Additive  ERBB2IP-1  1.0  395  0  0  2  0 
Additive  DLG3-2  1.0  2241  1  0  2  0 
Additive  LIN7B-1  1.0  2734  1  0  2  0 
Additive  DLG4-1  0.9375  1960  2  0  2  0 
Additive  DLG4-2  0.9375  2041  2  0  2  0 
Additive  PDZK1-1  0.8125  0  0  0  1  0 
Additive  MLLT4-1  0.6875  93  1  0  6  0 
Additive  MAGI3-1  1.0  1846  0  0  1  0 
Additive  MAGI2-2  1.0  2406  1  0  1  0 
Additive  SNTG1-1  1.0  1723  1  0  1  0 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
PWM  DLG1-1  1.0  412  1  0  2  0 
PWM  DLG1-2  1.0  412  3  0  3  0 
PWM  MPDZ-10  1.0  412  4  0  4  0 
PWM  ERBB2IP-1  1.0  412  2  0  2  0 
PWM  DLG3-2  1.0  412  1  0  2  0 
PWM  LIN7B-1  1.0  412  2  0  2  0 
PWM  DLG4-1  0.9375  412  1  0  2  0 
PWM  DLG4-2  0.9375  412  2  0  2  0 
PWM  PDZK1-1  0.8125  412  1  0  1  0 
PWM  MLLT4-1  0.6875  412  2  0  6  0 
PWM  MAGI3-1  1.0  412  0  0  1  0 
PWM  MAGI2-2  1.0  412  0  0  1  0 
PWM  SNTG1-1  1.0  412  1  0  1  0 
 
Worm 
The worm proteome was scanned to predict interactions for 6 worm PDZ domains with 
positive and negative interactions from protein microarray experiments [3]. In total, 
19,864 unique transcript tails of length five out of 27,533 transcripts corresponding to   - 14 - 
20,158 genes in the worm proteome were scanned (defined by genome assembly 
Ensembl:WS200.56) [7]. 
 
Table S6. The following table summarizes the worm proteome scanning results for the 
SVM, MDSM, Additive and PWM predictors 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
SVM  DLG1-1  0.8125  44  1  1  4  18 
SVM  DLG1-3  0.9375  87  4  1  7  15 
SVM  DSH-1  0.8125  14  0  0  11  4 
SVM  LIN7-1  1.0  159  3  1  11  11 
SVM  MPZ1-6  0.6875  144  4  0  18  4 
SVM  STN2-1  0.8125  256  3  0  8  14 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
MDSM  DLG1-1  0.75  110  1  1  4  18 
MDSM  DLG1-3  0.9375  168  4  1  7  15 
MDSM  DSH-1  0.8125  2598  3  0  11  4 
MDSM  LIN7-1  1.0  61  1  0  11  11 
MDSM  MPZ1-6  0.6875  85  0  0  18  4 
MDSM  STN2-1  0.8125  200  3  1  8  14 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
Additive  DLG1-1  0.8125  730  2  4  4  18 
Additive  DLG1-3  0.9375  864  4  3  7  15 
Additive  DSH-1  0.8125  79  0  0  11  4 
Additive  LIN7-1  1.0  1177  7  2  11  11 
Additive  MPZ1-6  0.6875  713  3  0  18  4 
Additive  STN2-1  0.8125  1086  4  2  8  14 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
PWM  DLG1-1  0.8125  199  2  4  4  18 
PWM  DLG1-3  0.9375  199  1  2  7  15 
PWM  DSH-1  0.8125  199  1  0  11  4 
PWM  LIN7-1  1.0  199  3  2  11  11 
PWM  MPZ1-6  0.6875  199  3  1  18  4 
PWM  STN2-1  0.8125  199  4  2  8  14 
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Fly 
The fly proteome was scanned to predict interactions for 7 fly PDZ domains with positive 
and negative interactions from protein microarray experiments [3]. In total, 14,691 
unique transcript tails of length five out of 21,309 transcripts corresponding to 20,158 
genes were scanned (defined by genome assembly Ensembl:BDGP5.13.56) [7]. 
 
Table S7. The following table summarizes the fly proteome scanning results for the 
SVM, MDSM, Additive and PWM predictors 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
SVM  MAGI-4  0.8125  92  2  3  2  17 
SVM  DLG1-1  0.9375  112  4  0  4  15 
SVM  DSH-1  0.9375  49  0  0  3  16 
SVM  LAP4-2  0.875  30  3  1  5  14 
SVM  LAP4-3  0.75  8  2  0  8  11 
SVM  PAR6-1  1.0  0  0  0  1  18 
SVM  PATJ-2  0.8125  184  0  0  7  12 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
MDSM  MAGI-4  0.8125  192  0  0  2  17 
MDSM  DLG1-1  0.9375  76  2  2  4  15 
MDSM  DSH-1  0.9375  1641  2  3  3  16 
MDSM  LAP4-2  0.875  8  0  0  5  14 
MDSM  LAP4-3  0.75  95  4  1  8  11 
MDSM  PAR6-1  1.0  3  0  0  1  18 
MDSM  PATJ-2  0.625  5  1  0  7  12 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
Additive  MAGI-4  0.8125  843  2  6  2  17 
Additive  DLG1-1  0.9375  849  4  3  4  15 
Additive  DSH-1  0.9375  98  0  0  3  16 
Additive  LAP4-2  0.875  307  4  1  5  14 
Additive  LAP4-3  0.75  300  3  0  8  11 
Additive  PAR6-1  1.0  18  0  0  1  18 
Additive  PATJ-2  0.625  30  0  0  7  12 
Method  Domain  NN 
Sim 
Num 
Predicted 
#TP  #FP  #Valid 
Positives 
#Valid 
Negatives 
PWM  MAGI-4  0.8125  147  0  3  2  17   - 16 - 
PWM  DLG1-1  0.9375  147  4  2  4  15 
PWM  DSH-1  0.9375  147  1  3  3  16 
PWM  LAP4-2  0.875  147  5  3  5  14 
PWM  LAP4-3  0.75  147  4  2  8  11 
PWM  PAR6-1  1.0  147  0  0  1  18 
PWM  PATJ-2  0.8125  147  0  1  7  12 
 
G. Binding sequence similarity calculation 
The distance between two domain binding site sequences a and b of the same length n is 
calculated as the Hamming distance between the two sequences (Equation 1). The 
sequence similarity between the two sequences is therefore 1.0 minus the Hamming 
distance (Equation 2): 
€ 
Distanceseq(a,b) =
match(ai
i=n
n
∑ ,bi)
n − gap(ai,bi)
i=1
n
∑  
(1) 
€ 
Similarityseq(a,b) =1.0−Distanceseq(a,b)  (2) 
 
where match is 1 if ai=bi , otherwise 0, gap equals 1 if ai or bi is a gap, otherwise 0. 
H. Binding specificity similarity calculation 
The distance between two PWMs a and b is the normalized Euclidean distance  (Equation 
3). The similarity between two profiles is therefore 1 minus the distance: 
€ 
DistancePWM (a,b) =
1
2
(ai,L −bi,L)
2
L∈{20aa's}
∑
i=1
w
∑   (3) 
€ 
SimilarityPWM (a,b) =1.0−DistancePWM (a,b)  (4) 
 
where w is the number of columns in the PWM. This metric is normalized such that 0 
represents perfectly similar PWMs and 1 represents perfectly dissimilar PWMs.   - 17 - 
I. Comparison of genomic phage display and predicted 
sequence logos 
Genomic phage display sequence logos were created by scanning the human proteome 
for the top 1% of binders using the PWMs created with optimal phage display binders.  
The optimal and genomic phage display sequence logos were then compared to the 
corresponding SVM predicted sequence logos. 
 
Figure S2. The following is a comparison of the optimal phage display and genomic 
phage display sequence logos compared to the corresponding predicted SVM sequence 
logos for the last five terminal binding positions.  Only the four human PDZ domains 
from Figure 4 of the paper were compared. 
 
Domain
Name
NN
Sim
Optimal Genomic SVM
Predicted
Optimal
Profile
Sim
Genomic
Profile
Sim
DLG1-2
Human
1 0.751 0.886
DLG3-2
Human
1 0.682 0.86
MLLT4-1
Human
0.69 0.62 0.624
PDZK1-1
Human
0.81 0.691 0.851  - 18 - 
J. Comparison of the performance of MDSM and SVM 
trained using only microarray data 
To more directly compare the MDSM and SVM, we trained an SVM with only mouse 
microarray data and compared the performance of the predictors.   
 
Figure S3. The following is a comparison of MDSM and SVM performance evaluated 
using F1 measures and FPRs for 13 human (blue), 6 worm (green) and 7 fly (black) PDZ 
domains.  The median is denoted by the red circle. No FPRs were calculated for human 
predictions since there are no negative human validation interaction data.  Both predictors 
were trained using microarray training data only. 
 
K. Protein protein interaction evidence to support PDZ 
domain peptide predictions 
Physical human protein protein interactions (PPIs) were collected from eight interaction 
databases (BIND, BioGRID, CORUM, DIP, HPRD, IntAct, MINT and MPPI) through 
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the iRefIndex database [8]. Only interactions annotated with UniProt ids from 
UniProtKB/Swiss-Prot were used (since the corresponding sequences were manually 
annotated and reviewed).  A PPI was counted as corresponding to a domain peptide 
interaction prediction if the protein containing the domain was found in iRefIndex to 
interact with the protein containing the peptide. To test the significance of the number of 
predictions found to be in iRefIndex for a given domain, a Fisher’s exact test was 
performed and asked whether the observed number predictions could be achieved at 
random.  In total, 213 human PDZ domains with PPIs in iRefIndex were analyzed.  The 
SVM predicted interactions for 192 domains with 75 domains having predictions 
corresponding to at least one iRefIndex interaction.  The SVM did not make predictions 
for the remaining 21 domains. 
 
Table S8.  The following table lists the identities of the 75 human PDZ domains whose 
proteome predicts corresponded to at least one protein-protein interacion from iRefIndex.  
UniProt Domain Name is the name of the domain using the UniProt protein name.  
UniProt Domain Sequence Positions are the start and end positions of the domain 
sequence along the UniProt protein sequence.  UniProt ID is the identifier of the UniProt 
protein.  Tonikian Domain Name is the name of the domain used in Tonikian et al. 
UniProt 
Domain Name 
UniProt 
Domain Sequence 
Positions 
UniProt ID  Tonikian 
Domain Name 
 ARHGC-1  72-151  Q9NZN5   
GIPC1-1  133-213  O14908   
LIN7B-1  93-175  Q9HAP6   
MAGI2-1  17-101  Q86UL8   
MAGI2-2  426-510  Q86UL8   
MAGI2-4  778-860  Q86UL8    
MAGI2-5  920-1010  Q86UL8     - 20 - 
MAGI2-3  605-683  Q86UL8   
MAGI2-6  1147-1229  Q86UL8   
MAST2-1  967-1055  Q9Y2H9   
MPP3-1  137-212  Q13368   
NHRF1-1  14-94  O14745   
NHRF1-2  154-234  O14745   
NHRF3-2  134-215  Q5T2W1   
NHRF3-4  378-458  Q5T2W1   
NHRF3-3  243-323  Q5T2W1   
NHRF4-1  115-196  Q86UT5   
NHRF4-3  329-412  Q86UT5   
PDLI1-1  3-85  O00151   
PDZ11-1  47-129  Q5EBL8   
PDZD2-2  334-419  O15018   
PTN3-1  510-582  P26045   
RGS12-1  22-98  O14924   
RGS3-1  299-376  P49796   
SHAN1-1  663-757  Q9Y566   
SHAN2-1  247-341  Q9UPX8   
SNTB1-1  112-195  Q13884   
SNTB2-1  115-198  Q13425   
SNTG1-1  57-140  Q9NSN8   
SNTG2-1  73-156  Q9NY99   
SYJ2B-1  13-100  P57105   
APBA3-2  485-560  O96018   
DLG3-1  130-217  Q92796   
DLG3-3  379-465  Q92796   
DLG4-2  160-246  P78352   
DLG4-1  65-151  P78352   
INADL-8  1437-1520  Q8NI35   
MPDZ-8  1350-1433  O75970   
NHRF2-1  11-90  Q15599   
PARD3-3  590-680  Q8TEW0  PARD3-3 
MPDZ-4  565-630  O75970  MPDZ-4 
MPDZ-7  1151-1239  O75970  MPDZ-7 
MPDZ-10  1629-1708  O75970  MPDZ-10 
MPDZ-13  1959-2038  O75970  MPDZ-13 
NHRF2-2  151-227  Q15599  SLC9A3R2-2 
DLG4-3  313-390  P78352  DLG4-3 
MPDZ-2  257-333  O75970  MPDZ-2 
SCRIB-4  1110-1194  Q14160   
ZO2-1  33-120  Q9UDY2   
DLG1-1  224-307  Q12959  DLG1-1 
DLG1-2  319-402  Q12959  DLG1-2 
DLG1-3  466-543  Q12959  DLG1-3   - 21 - 
DLG3-2  226-309  Q92796  DLG3-2 
MAGI1-2  472-554  Q96QZ7   
MAGI1-3  634-719  Q96QZ7  MAGI1-2 
MAGI1-4  813-895  Q96QZ7   
MAGI1-6  1124-1206  Q96QZ7   
MAGI3-4  751-831  Q5TCQ9  MAGI3-3 
MAGI3-5  876-963  Q5TCQ9   
MAGI3-5  1046-1128  Q5TCQ9   
PTN13-2  368-1449  Q12923  PTPN13-2 
SCRIB-1  728-811  Q14160  SCRIB-1 
SCRIB-2  862-947  Q14160  SCRIB-2 
SCRIB-3  1004-1093  Q14160   
DLG2-2  193-279  Q15700   
DLG2-1  98-184  Q15700   
DLG2-3  421-501  Q15700   
LAP2-1  1323-1406  Q96RT1  ERBB2IP-1 
LRRC7-1  1448-1531  Q96NW7  LRRC7-1 
CSKP-1  490-566  O14936  CASK-1 
AFAD-1  1009-1087  P55196  MLLT4-1 
SNTA1-1  87-166  Q13424  SNTA1-1 
MAGI3-2  435-517  Q5TCQ9   
MAGI3-3  603-679  Q5TCQ9   
NHRF3-1  9-86  Q5T2W1  PDZK1-1 
 
Table S9.  The following table lists the number of predicted interactions that correspond 
to protein-protein interactions in iRefIndex for 75 human PDZ domains. UniProt Domain 
Name is the name of the domain using the UniProt protein name. 
UniProt 
Domain Name 
# iRefIndex 
PPIs 
predicted 
# iRefIndex 
PPIs 
p-value 
 ARHGC-1  1  14  0.566 
GIPC1-1  4  42  7.76e-06 
LIN7B-1  1  11  0.107 
MAGI2-1  1  10  0.124 
MAGI2-2  2  10  0.0117 
MAGI2-4  1  10  0.0325 
MAGI2-5  1  10  0.0344 
MAGI2-3  1  10  0.122 
MAGI2-6  1  10  0.0952 
MAST2-1  2  6  0.0017 
MPP3-1  1  1  0.000631   - 22 - 
NHRF1-1  15  57  7.45e-15 
NHRF1-2  24  57  1.74e-14 
NHRF3-2  1  24  0.0763 
NHRF3-4  3  24  0.00141 
NHRF3-3  8  24  3.08e-06 
NHRF4-1  1  5  0.0408 
NHRF4-3  3  5  0.000206 
PDLI1-1  1  14  0.0748 
PDZ11-1  1  4  0.0307 
PDZD2-2  1  5  0.123 
PTN3-1  1  5  0.0861 
RGS12-1  4  19  0.000715 
RGS3-1  3  11  0.026 
SHAN1-1  2  21  0.0913 
SHAN2-1  1  13  0.364 
SNTB1-1  4  14  9.74e-06 
SNTB2-1  3  20  0.00105 
SNTG1-1  1  12  0.181 
SNTG2-1  1  1  0.0114 
SYJ2B-1  3  5  5.71e-05 
APBA3-2  1  7  0.00289 
DLG3-1  9  48  3.98e-11 
DLG3-3  7  48  1.95e-07 
DLG4-2  14  130  2.88e-11 
DLG4-1  13  130  7.37e-12 
INADL-8  1  15  0.0653 
MPDZ-8  1  9  0.0141 
NHRF2-1  12  44  2.48e-12 
PARD3-3  1  26  0.0311 
MPDZ-4  2  9  0.0081 
MPDZ-7  1  9  0.027 
MPDZ-10  4  9  6.53e-08 
MPDZ-13  1  9  0.0137 
NHRF2-2  15  44  2.33e-11 
DLG4-3  13  130  1.41e-10 
MPDZ-2  1  9  0.0591 
SCRIB-4  1  11  0.0534 
ZO2-1  1  11  0.0844 
DLG1-1  13  83  1.98e-14 
DLG1-2  14  83  5.21e-14 
DLG1-3  10  83  3.09e-09 
DLG3-2  9  48  6.6e-10 
MAGI1-2  4  24  0.00014 
MAGI1-3  3  24  0.000176 
MAGI1-4  2  24  0.000724   - 23 - 
MAGI1-6  6  24  4.54e-05 
MAGI3-4  1  12  0.0426 
MAGI3-5  1  12  0.0256 
MAGI3-6  1  12  0.31 
PTN13-2  1  23  0.111 
SCRIB-1  1  11  0.0357 
SCRIB-2  1  11  0.0292 
SCRIB-3  1  11  0.161 
DLG2-2  8  41  4.28e-09 
DLG2-1  8  41  3.53e-10 
DLG2-3  6  41  1.46e-06 
LAP2-1  2  33  0.00203 
LRRC7-1  2  13  0.000731 
CSKP-1  3  53  0.0396 
AFAD-1  1  58  0.0495 
SNTA1-1  4  28  9.53e-05 
MAGI3-2  5  12  1.31e-05 
MAGI3-3  1  12  0.0199 
NHRF3-1  4  24  0.000272 
 
L. GO biological process term enrichment 
GO biological process term enrichment analysis was performed to determine statistically 
overrepresented annotations in the genes of predicted binders for the PDZ domains used 
in proteome scanning tests.  The hypergeometric test was used to compute a p-value to 
assess GO term enrichment for a set of predicted genes.  Since this results in testing the 
significance of all GO terms in the given set of genes in a single analysis, multiple testing 
correction was performed using the Benjamini and Hochberg False Discovery Rate 
(FDR) correction with a significance level of 0.05.  The BiNGO (Biological Network 
Gene Ontology tool) [9] software library was used. Only manually annotated GO terms 
were used. 
   - 24 - 
Table S10. The following table lists the enriched GO biological process terms in genes of 
predicted binders for 13 human PDZ domains used for proteome scanning.  GO ID is the 
GO process term identifier, p-value is the hypergeometric test statistic corrected for 
multiple testing, Description is the GO term description.  GO terms are ordered by 
increasing p-value.  Only GO terms with p < 0.05 are displayed.  Domains with no terms 
satisfying this cutoff are indicated by an asterisk and only the top 10 GO terms are 
displayed. 
DLG1-1-Human 
GO ID  p-value  Description 
6813  2.658E-3  potassium ion transport 
30001  2.658E-3  metal ion transport 
6811  3.062E-3  ion transport 
6812  3.481E-3  cation transport 
15672  8.531E-3  monovalent inorganic cation transport 
DLG1-2-Human 
GO ID  p-value  Description 
6811  2.774E-4  ion transport 
6813  2.167E-3  potassium ion transport 
6812  5.264E-3  cation transport 
30001  5.264E-3  metal ion transport 
6810  1.151E-2  transport 
15672  1.685E-2  monovalent inorganic cation transport 
51234  2.034E-2  establishment of localization 
DLG3-2-Human 
GO ID  p-value  Description 
6811  2.774E-4  ion transport 
6813  2.167E-3  potassium ion transport 
6812  5.264E-3  cation transport 
30001  5.264E-3  metal ion transport 
6810  1.151E-2  transport 
15672  1.685E-2  monovalent inorganic cation transport 
51234  2.034E-2  establishment of localization 
DLG4-1-Human 
GO ID  p-value  Description 
6813  2.658E-3  potassium ion transport 
30001  2.658E-3  metal ion transport 
6811  3.062E-3  ion transport 
6812  3.481E-3  cation transport   - 25 - 
15672  8.531E-3  monovalent inorganic cation transport 
DLG4-2-Human 
GO ID  p-value  Description 
6811  2.774E-4  ion transport 
6813  2.167E-3  potassium ion transport 
6812  5.264E-3  cation transport 
30001  5.264E-3  metal ion transport 
6810  1.151E-2  transport 
15672  1.685E-2  monovalent inorganic cation transport 
51234  2.034E-2  establishment of localization 
ERBB2IP-1-Human * 
GO ID  p-value  Description 
32581  2.557E-1  ER-dependent peroxisome biogenesis 
16557  2.557E-1  peroxisome membrane biogenesis 
45046  2.557E-1  protein import into peroxisome membrane 
55114  2.557E-1  oxidation reduction 
6338  2.557E-1  chromatin remodeling 
7155  2.557E-1  cell adhesion 
22610  2.557E-1  biological adhesion 
51016  2.557E-1  barbed-end actin filament capping 
51693  2.557E-1  actin filament capping 
15917  2.557E-1  aminophospholipid transport 
LIN7B-1-Human * 
GO ID  p-value  Description 
6811  1.414E-1  ion transport 
35176  1.414E-1  social behavior 
6813  1.414E-1  potassium ion transport 
6812  1.414E-1  cation transport 
30001  1.414E-1  metal ion transport 
30516  1.414E-1  regulation of axon extension 
32927  1.414E-1  positive regulation of activin receptor signaling 
pathway 
51705  1.414E-1  behavioral interaction between organisms 
1935  1.414E-1  endothelial cell proliferation 
50808  1.414E-1  synapse organization and biogenesis 
MAGI2-2-Human * 
GO ID  p-value  Description 
7389  3.909E-1  pattern specification process 
35176  3.909E-1  social behavior 
6812  3.909E-1  cation transport 
6810  3.909E-1  transport 
7264  3.909E-1  small GTPase mediated signal transduction 
6813  3.909E-1  potassium ion transport 
51234  3.909E-1  establishment of localization 
51179  3.909E-1  localization   - 26 - 
32927  3.909E-1  positive regulation of activin receptor signaling 
pathway 
51705  3.909E-1  behavioral interaction between organisms 
MAGI3-1-Human 
GO ID  p-value  Description 
6813  1.458E-2  potassium ion transport 
51234  1.768E-2  establishment of localization 
6810  1.768E-2  transport 
6811  1.768E-2  ion transport 
51179  1.768E-2  localization 
MLLT4-1-Human * 
GO ID  p-value  Description 
33081  5.388E-2  regulation of T cell differentiation in the thymus 
46620  5.388E-2  regulation of organ growth 
303  5.388E-2  response to superoxide 
45541  5.388E-2  negative regulation of cholesterol biosynthetic 
process 
48538  5.388E-2  thymus development 
45939  5.388E-2  negative regulation of steroid metabolic process 
45540  5.388E-2  regulation of cholesterol biosynthetic process 
1890  5.388E-2  placenta development 
305  5.388E-2  response to oxygen radical 
50810  7.339E-2  regulation of steroid biosynthetic process 
MPDZ-10-Human * 
GO ID  p-value  Description 
6813  7.25E-2  potassium ion transport 
1508  1.822E-1  regulation of action potential 
30001  1.822E-1  metal ion transport 
15672  1.822E-1  monovalent inorganic cation transport 
6342  1.822E-1  chromatin silencing 
31507  1.822E-1  heterochromatin formation 
42391  1.822E-1  regulation of membrane potential 
45814  1.822E-1  negative regulation of gene expression, epigenetic 
6812  1.822E-1  cation transport 
19226  1.822E-1  transmission of nerve impulse 
PDZK1-1-Human 
GO ID  p-value  Description 
6811  2.389E-4  ion transport 
45494  5.702E-3  photoreceptor cell maintenance 
SNTG1-1-Human 
GO ID  p-value  Description 
6810  2.251E-2  transport 
51234  2.251E-2  establishment of localization 
46942  3.625E-2  carboxylic acid transport 
6813  3.625E-2  potassium ion transport   - 27 - 
15849  3.625E-2  organic acid transport 
 
Table S11.  The following table lists the enriched GO biological process terms in genes 
of predicted binders for 6 worm PDZ domains used for proteome scanning.  GO ID is the 
GO process term identifier, p-value is the hypergeometric test statistic corrected for 
multiple testing, Description is the GO term description. GO terms are ordered by 
increasing p-value.  Only GO terms with p < 0.05 are displayed.  Domains with no terms 
satisfying this cutoff are indicated by an asterisk and only the top 10 GO terms are 
displayed. 
DLG1-1-Worm 
GO ID  p-value  Description 
35046  5.259E-3  pronuclear migration 
7097  5.259E-3  nuclear migration 
7338  5.259E-3  single fertilization 
51647  5.259E-3  nucleus localization 
40023  5.259E-3  establishment of nucleus localization 
9566  5.259E-3  fertilization 
51656  1.647E-2  establishment of organelle localization 
51640  1.647E-2  organelle localization 
51649  2.844E-2  establishment of localization in cell 
51641  2.844E-2  cellular localization 
48755  2.844E-2  branching morphogenesis of a nerve 
1763  2.844E-2  morphogenesis of a branching structure 
51179  3.099E-2  localization 
7166  3.099E-2  cell surface receptor linked signal transduction 
8039  3.099E-2  synaptic target recognition 
33673  3.099E-2  negative regulation of kinase activity 
7219  3.099E-2  Notch signaling pathway 
43407  3.099E-2  negative regulation of MAP kinase activity 
6469  3.099E-2  negative regulation of protein kinase activity 
43086  3.099E-2  negative regulation of catalytic activity 
51348  3.099E-2  negative regulation of transferase activity 
8543  3.099E-2  fibroblast growth factor receptor signaling 
pathway 
7154  3.31E-2  cell communication 
19953  3.31E-2  sexual reproduction 
51234  4.794E-2  establishment of localization   - 28 - 
7052  4.927E-2  mitotic spindle organization and biogenesis 
43405  4.992E-2  regulation of MAP kinase activity 
8151  4.992E-2  cellular process 
7051  4.992E-2  spindle organization and biogenesis 
50808  4.992E-2  synapse organization and biogenesis 
51338  4.992E-2  regulation of transferase activity 
31344  4.992E-2  regulation of cell projection organization and 
biogenesis 
43549  4.992E-2  regulation of kinase activity 
45859  4.992E-2  regulation of protein kinase activity 
DLG1-3-Worm 
GO ID  p-value  Description 
35046  2.409E-2  pronuclear migration 
7097  2.409E-2  nuclear migration 
7338  2.409E-2  single fertilization 
51647  2.409E-2  nucleus localization 
40023  2.409E-2  establishment of nucleus localization 
9566  2.409E-2  fertilization 
DSH-1-Worm * 
GO ID  p-value  Description 
40017  2.168E-1  positive regulation of locomotion 
40012  2.168E-1  regulation of locomotion 
40015  6.368E-1  negative regulation of multicellular organism 
growth 
51241  6.368E-1  negative regulation of multicellular organismal 
process 
45926  6.368E-1  negative regulation of growth 
40035  6.413E-1  hermaphrodite genitalia development 
48806  6.413E-1  genitalia development 
7548  6.413E-1  sex differentiation 
3006  6.413E-1  reproductive developmental process 
48513  6.413E-1  organ development 
LIN7-1-Worm * 
GO ID  p-value  Description 
50793  1.159E-1  regulation of developmental process 
51656  1.159E-1  establishment of organelle localization 
51640  1.159E-1  organelle localization 
40028  1.159E-1  regulation of vulval development 
35046  1.159E-1  pronuclear migration 
226  1.159E-1  microtubule cytoskeleton organization and 
biogenesis 
7097  1.159E-1  nuclear migration 
7338  1.159E-1  single fertilization 
51647  1.159E-1  nucleus localization 
40023  1.159E-1  establishment of nucleus localization   - 29 - 
MPZ1-6-Worm * 
GO ID  p-value  Description 
6937  1.694E-1  regulation of muscle contraction 
22604  1.694E-1  regulation of cell morphogenesis 
7154  1.694E-1  cell communication 
50793  1.694E-1  regulation of developmental process 
8151  1.694E-1  cellular process 
10248  1.694E-1  establishment and/or maintenance of 
transmembrane electrochemical gradient 
45750  1.694E-1  positive regulation of S phase of mitotic cell cycle 
48755  1.694E-1  branching morphogenesis of a nerve 
1763  1.694E-1  morphogenesis of a branching structure 
51179  1.694E-1  localization 
STN2-1-Worm * 
GO ID  p-value  Description 
50793  2.807E-1  regulation of developmental process 
22604  2.807E-1  regulation of cell morphogenesis 
10248  2.807E-1  establishment and/or maintenance of 
transmembrane electrochemical gradient 
45750  2.807E-1  positive regulation of S phase of mitotic cell cycle 
7166  2.807E-1  cell surface receptor linked signal transduction 
45167  2.807E-1  asymmetric protein localization during cell fate 
commitment 
51656  2.807E-1  establishment of organelle localization 
51640  2.807E-1  organelle localization 
35046  2.807E-1  pronuclear migration 
51179  2.807E-1  localization 
 
Table S12.  The following table lists the enriched GO biological process terms in genes 
of predicted binders for 6 fly PDZ domains used for proteome scanning (with SVM 
predictions).  GO ID is the GO process term identifier, p-value is the hypergeometric test 
statistic corrected for multiple testing, Description is the GO term description. GO terms 
are ordered by increasing p-value.  Only GO terms with p < 0.05 are displayed.  Domains 
with no terms satisfying this cutoff are indicated by an asterisk and only the top 10 GO 
terms are displayed. 
DLG1-1-Fly 
GO ID  p-value  Description   - 30 - 
16337  6.252E-4  cell-cell adhesion 
7156  2.479E-2  homophilic cell adhesion 
7155  2.479E-2  cell adhesion 
22610  3.779E-2  biological adhesion 
DSH-1-Fly * 
GO ID  p-value  Description 
7476  6.294E-2  imaginal disc-derived wing morphogenesis 
7472  6.294E-2  wing disc morphogenesis 
48082  6.294E-2  regulation of adult chitin-containing cuticle 
pigmentation 
48079  6.294E-2  regulation of cuticle pigmentation 
7480  6.294E-2  imaginal disc-derived leg morphogenesis 
35114  6.294E-2  imaginal disc-derived appendage morphogenesis 
48737  6.294E-2  imaginal disc-derived appendage development 
35107  6.294E-2  appendage morphogenesis 
35220  6.294E-2  wing disc development 
48736  6.294E-2  appendage development 
LAP4-2-Fly * 
GO ID  p-value  Description 
30038  1.47E-1  contractile actin filament bundle formation 
16337  1.47E-1  cell-cell adhesion 
48150  1.47E-1  behavioral response to ether 
6207  1.47E-1  'de novo' pyrimidine base biosynthetic process 
45472  1.47E-1  response to ether 
34404  1.47E-1  nucleobase, nucleoside and nucleotide biosynthetic 
process 
46112  1.47E-1  nucleobase biosynthetic process 
19856  1.47E-1  pyrimidine base biosynthetic process 
48644  1.47E-1  muscle morphogenesis 
6206  1.602E-1  pyrimidine base metabolic process 
LAP4-3-Fly * 
GO ID  p-value  Description 
14902  6.15E-2  myotube differentiation 
768  6.15E-2  syncytium formation by plasma membrane fusion 
6949  6.15E-2  syncytium formation 
6947  6.15E-2  plasma membrane fusion 
7520  6.15E-2  myoblast fusion 
48627  6.15E-2  myoblast development 
48628  6.15E-2  myoblast maturation 
45445  6.15E-2  myoblast differentiation 
6944  6.15E-2  membrane fusion 
48469  6.15E-2  cell maturation 
MAGI-Fly * 
GO ID  p-value  Description 
16339  2.161E-1  calcium-dependent cell-cell adhesion   - 31 - 
7413  2.161E-1  axonal fasciculation 
7155  2.161E-1  cell adhesion 
7409  2.161E-1  axonogenesis 
44265  2.161E-1  cellular macromolecule catabolic process 
48675  2.161E-1  axon extension 
22610  2.161E-1  biological adhesion 
6393  2.161E-1  termination of mitochondrial transcription 
6390  2.161E-1  transcription from mitochondrial promoter 
8040  2.161E-1  axon guidance 
PATJ-2-Fly * 
GO ID  p-value  Description 
48133  1.978E-1  male germ-line stem cell division 
42078  3.139E-1  germ-line stem cell division 
17145  3.139E-1  stem cell division 
45786  3.139E-1  negative regulation of cell cycle 
16199  3.139E-1  axon midline choice point recognition 
7346  3.139E-1  regulation of mitotic cell cycle 
46864  3.139E-1  isoprenoid transport 
45910  3.139E-1  negative regulation of DNA recombination 
46866  3.139E-1  tetraterpenoid transport 
46865  3.139E-1  terpenoid transport 
   - 32 - 
References 
1.  LIBSVM: a library for support vector machines 
[http://www.csie.ntu.edu.tw/~cjlin/libsvm] 
2.  Tonikian R, Zhang Y, Sazinsky SL, Currell B, Yeh JH, Reva B, Held HA, 
Appleton BA, Evangelista M, Wu Y, et al: A specificity map for the PDZ 
domain family. PLoS Biol 2008, 6:e239. 
3.  Chen JR, Chang BH, Allen JE, Stiffler MA, MacBeath G: Predicting PDZ 
domain-peptide interactions from primary sequences. Nat Biotechnol 2008, 
26:1041-1045. 
4.  Skelton NJ, Koehler MF, Zobel K, Wong WL, Yeh S, Pisabarro MT, Yin JP, 
Lasky LA, Sidhu SS: Origins of PDZ domain ligand specificity. Structure 
determination and mutagenesis of the Erbin PDZ domain. J Biol Chem 2003, 
278:7645-7654. 
5.  Stiffler MA, Chen JR, Grantcharova VP, Lei Y, Fuchs D, Allen JE, Zaslavskaia 
LA, MacBeath G: PDZ domain binding selectivity is optimized across the 
mouse proteome. Science 2007, 317:364-369. 
6.  Beuming T, Skrabanek L, Niv MY, Mukherjee P, Weinstein H: PDZBase: a 
protein-protein interaction database for PDZ-domains. Bioinformatics 2005, 
21:827-828.   - 33 - 
7.  Hubbard TJP, Aken BL, Ayling S, Ballester B, Beal K, Bragin E, Brent S, Chen 
Y, Clapham P, Clarke L, et al: Ensembl 2009. Nucleic Acids Res 2009, 37:D690-
D697. 
8.  Razick S, Magklaras G, Donaldson IM: iRefIndex: A consolidated protein 
interaction database with provenance. BMC Bioinformatics 2008, 9:405. 
9.  Maere S, Heymans K, Kuiper M: BiNGO: a Cytoscape plugin to assess 
overrepresentation of Gene Ontology categories in Biological Networks. 
Bioinformatics 2005, 21:3448-3449. 
 
 